当前位置：
X-MOL 学术
›
Carcinogenesis
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
DCLK1 integrates induction of TRIB3, EMT, drug resistance and poor prognosis in colorectal cancer.
Carcinogenesis ( IF 3.3 ) Pub Date : 2020-05-14 , DOI: 10.1093/carcin/bgaa016 Shunichiro Makino 1 , Hidekazu Takahashi 1 , Daisuke Okuzaki 2 , Norikatsu Miyoshi 1 , Naotsugu Haraguchi 1 , Taishi Hata 1 , Chu Matsuda 1 , Hirofumi Yamamoto 1 , Tsunekazu Mizushima 1 , Masaki Mori 1, 3 , Yuichiro Doki 1
中文翻译：
DCLK1整合了TRIB3的诱导，EMT，耐药性和结直肠癌预后不良。
更新日期：2020-05-14
Carcinogenesis ( IF 3.3 ) Pub Date : 2020-05-14 , DOI: 10.1093/carcin/bgaa016 Shunichiro Makino 1 , Hidekazu Takahashi 1 , Daisuke Okuzaki 2 , Norikatsu Miyoshi 1 , Naotsugu Haraguchi 1 , Taishi Hata 1 , Chu Matsuda 1 , Hirofumi Yamamoto 1 , Tsunekazu Mizushima 1 , Masaki Mori 1, 3 , Yuichiro Doki 1
Affiliation
中文翻译：
DCLK1整合了TRIB3的诱导，EMT，耐药性和结直肠癌预后不良。
京公网安备 11010802027423号